Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.2600 (-1.31%) ($8.0800 - $8.4000) on Thu. Feb. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 33 | Latest Price | $8.2600(-1.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(5%) IBB(3%) TBT(3%) BLOK(2%) KWEB(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.805% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
1 - 5 Day Possible Target | $2.42(-70.7%) | Resistance Level | $8.83 | 5 Day Moving Average | $8.53(-3.17%) | 10 Day Moving Average | $8.71(-5.17%) | 20 Day Moving Average | $8.83(-6.46%) | To recent high | -15% | To recent low | 17% | Market Cap | $1.457b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |